Haha,
i love your post. Perineal biopsies are not new by any means. The papers you posted are consistent hypothesis. Not one single evidence based level 1 trial that stands the test of a phase III trial. All decent papers. Some wrought with bias and some just stating retrospective points of view ~ with bias. Conclusions that say "We believe" or "appears" or "we think" etc. These are not the best evidence I subscribe to.
The problem with evidence right now on targeted biopsy is that we need the paper. Without it I can load us both up with counter points:
MP-MRI can reduce biopsy core sampling?
www.ncbi.nlm.nih.gov/pmc/articles/PMC4122009/www.europeanurology.com/article/S0302-2838(15)00036-6/fulltext/can-clinically-significant-prostate-cancer-be-detected-with-multiparametric-magnetic-resonance-imaging-a-systematic-review-of-the-literatureGeneral Discussion
www.ncbi.nlm.nih.gov/pmc/articles/PMC4094966/No Advantage with PB:
www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382014000100016I think we should take this conversation offline. I'll tell you what is being discussed by the researchers. That in fact the trials for targeted biopsy are coming. Until we have them, we have multiple discussions from various angles.
Points we agree on,
1. Perineal is safer generally than TRUS in regards to Septicemia.
2. We need better data.
Points we don't,
1. Perineal is not 100% safe and the use of the term negligible only highlights sepsis and E-Coli. But disregards the use of a general anesthesia which can have variable tolerances among patients.
2. MP-MRI, and other targeted methods, Can in fact reduce biopsies sessions. Can also in certain advanced circumstances eliminate biopsy. And can reduce the number of needed biopsy cores especially in patients that had previous biopsies that were negative.
3. Not all patients that had a bad experience will experience it again, and that a change in antibiotics can affect this.
4. Perineal biopsies to not have a better track record of detecting prostate cancers than TRUS. There is no evidence to support such a claim at a level 1 criteria.
Our friend John T is a great example of 100+ biopsy samples both TRUS and perineal that was missing a core element that Duke Bahn detected with one core taken. I know that is anecdotal but it is true. I have a couple guys that also had a similar experience.
I think we've probably confused this particular patient enough. I would be more than happy to entertain a one-on-one in a new thread. We can always learn from each other. But if we regulate that this new thread must contain Level 1 Phase III trial data and no study hypothesis?
You'll hear a pin drop.
Always love ya, Allen. I'll be down there again soon. We need to close the gap.
AUA2016 is in San Diego May 6-10. I'll be there discussing detection and well I cannot say.